Microscopic evaluation, molecular identification, antifungal susceptibility, and clinical outcomes in fusarium, aspergillus and, dematiaceous keratitis

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Gajjar, Devarshi U ^a,b   Pal, Anuradha K ^b   Ghodadra, Bharat K ^b   Vasavada, Abhay R ^b  

^a M S UNIVERSITY OF BARODA   (India)

^b ILADEVI CATARACT AND IOL RESEARCH CENTRE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; EYE DROPS; FLUCONAZOLE; INTERNAL TRANSCRIBED SPACER; INTERNAL TRANSCRIBED SPACER 1; INTERNAL TRANSCRIBED SPACER 2; INTERNAL TRANSCRIBED SPACER 4; ITRACONAZOLE; ITRAL; NATAMET; NATAMYCIN; NUFL UCON; RM 462; UNCLASSIFIED DRUG;

ADULT; ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ANTIMICROBIAL THERAPY; ARTICLE; ASPERGILLOSIS; ASPERGILLUS; ASPERGILLUS FLAVUS; ASPERGILLUS NIGER; ASPERGILLUS SYDOWII; ASPERGILLUS TAMARII; ASPERGILLUS TERREUS; ASPERGILLUS TUBINGENSIS; ASPERGILLUS VERSICOLOR; BROTH DILUTION; CHAETOMIUM; CHLAMYDOSPORE; CLADORRHINUM BULBILOSSUM; CLADOSPORIUM CLADOSPORIOIDES; CLINICAL FEATURE; CONTROLLED STUDY; CORNEA ULCER; CURVULARIA LUNATA; DEMATIACEOUS; EXSEROHILUM ROSTRATUM; FEMALE; FLUORESCENCE MICROSCOPY; FOLLOW UP; FUNGUS; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; FUSARIOSIS; FUSARIUM; FUSARIUM SOLANI; GENERAL CONDITION DETERIORATION; HUMAN; KERATOMYCOSIS; KERATOPLASTY; LASIODIPLODIA THEOBROMAE; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MORNING DOSAGE; MULTIPLE CYCLE TREATMENT; NONHUMAN; OUTCOME ASSESSMENT; PAPULASPORA; PROSPECTIVE STUDY; SYSTEMIC THERAPY; TOPICAL TREATMENT; VISUAL ACUITY; CLINICAL TRIAL; KERATITIS; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY;

ADULT; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS; FEMALE; FUSARIOSIS; FUSARIUM; HUMANS; KERATITIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84887432993     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/605308     Document Type: Article

References (44)

1. Chander J., Singla N., Agnihotri N., Arya S. K., Deep A., Keratomycosis in and around Chandigarh: a five-year study from a north Indian tertiary care hospital. Indian Journal of Pathology and Microbiology 2008 51 2 304 306 2-s2.0-46949092908 10.4103/0377-4929.41700
2. Chowdhary A., Singh K., Spectrum of fungal keratitis in North India. Cornea 2005 24 1 8 15 2-s2.0-11144244975 10.1097/01.ico.0000126435.25751.20
3. Deshpande S. D., Koppikar G. V., A study of mycotic keratitis in Mumbai. Indian Journal of Pathology and Microbiology 1999 42 1 81 87 2-s2.0-0032612534
4. Gopinathan U., Sharma S., Garg P., Rao G. N., Review of epidemiological features, microbiological diagnosis and treatment outcome of microbial keratitis: experience of over a decade. Indian Journal of Ophthalmology 2009 57 4 273 279 2-s2.0-68249150594 10.4103/0301-4738.53051
5. Bharathi M. J., Ramakrishnan R., Meenakshi R., Padmavathy S., Shivakumar C., Srinivasan M., Microbial keratitis in South India: Influence of risk factors, climate, and geographical variation. Ophthalmic Epidemiology 2007 14 2 61 69 2-s2.0-34247616006 10.1080/09286580601001347
6. Srinivasan M., Upadhyay M. P., Priyadarsini B., Mahalakshmi R., Whitcher J. P., Corneal ulceration in south-east Asia III: prevention of fungal keratitis at the village level in south India using topical antibiotics. British Journal of Ophthalmology 2006 90 12 1472 1475 2-s2.0-33845255284 10.1136/bjo.2006.103028
7. Tanure M. A. G., Cohen E. J., Sudesh S., Rapuano C. J., Laibson P. R., Spectrum of fungal keratitis at Wills eye hospital, Philadelphia, Pennsylvania. Cornea 2000 19 3 307 312 2-s2.0-0034126818 10.1097/00003226-200005000-00010
8. Schoch C. L., Seifert K. A., Huhndorf S., Robert V., Spouge J. L., Levesque C. A., Chen W., Nuclear ribosomal internal transcribed spacer (ITS) region as a universal DNA barcode marker for Fungi. Proceedings of the National Academy of Sciences of the United States of America 2012 109 16 6241 6246 2-s2.0-84859972408 10.1073/pnas.1117018109
9. Azor M., Gené J., Cano J., Guarro J., Universal in vitro antifungal resistance of genetic clades of the Fusarium solani species complex. Antimicrobial Agents and Chemotherapy 2007 51 4 1500 1503 2-s2.0-34247099621 10.1128/AAC.01618-06
10. Manikandan P., Varga J., Kocsubé S., Anita R., Revathi R., Németh T. M., Narendran V., Vágvölgyi C., Panneer Selvam K., Shobana C. S., Babu Singh Y. R., Kredics L., Epidemiology of Aspergillus keratitis at a tertiary care eye hospital in South India and antifungal susceptibilities of the causative agents. Mycoses 2012 56 1 26 33 2-s2.0-84859484569 10.1111/j.1439-0507.2012.02194.x
11. O'Donnell K., Sutton D. A., Fothergill A., McCarthy D., Rinaldi M. G., Brandt M. E., Zhang N., Geiser D. M., Molecular phylogenetic diversity, multilocus haplotype nomenclature, and in vitro antifungal resistance within the Fusarium solani species complex. Journal of Clinical Microbiology 2008 46 8 2477 2490 2-s2.0-53149086711 10.1128/JCM.02371-07
12. Oechsler R. A., Feilmeier M. R., Miller D., Fusarium keratitis: genotyping, in vitro susceptibility and clinical outcomes. Cornea 2013 32 5 667 673 10. 1097/ICO. 0b013e318277ac74
13. Lalitha P., Prajna N. V., Oldenburg C. E., Srinivasan M., Krishnan T., Mascarenhas J., Vaitilingam C. M., McLeod S. D., Zegans M. E., Porco T. C., Acharya N. R., Lietman T. M., Organism, minimum inhibitory concentration, and outcome in a fungal corneal ulcer clinical trial. Cornea 2012 31 6 662 667 10.1097/ICO.0b013e31823f8ae0
14. Lalitha P., Shapiro B. L., Srinivasan M., Prajna N. V., Acharya N. R., Fothergill A. W., Ruiz J., Chidambaram J. D., Maxey K. J., Hong K. C., McLeod S. D., Lietman T. M., Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis. Archives of Ophthalmology 2007 125 6 789 793 2-s2.0-34250310860 10.1001/archopht.125.6.789
15. Lalitha P., Vijaykumar R., Prajna N. V., Fothergill A. W., In vitro natamycin susceptibility of ocular isolates of Fusarium and Aspergillus species: comparison of commercially formulated natamycin eye drops to pharmaceutical-grade powder. Journal of Clinical Microbiology 2008 46 10 3477 3478 2-s2.0-53649090786 10.1128/JCM.00610-08
16. Pradhan L., Sharma S., Nalamada S., Sahu S. K., Das S., Garg P., Natamycin in the treatment of keratomycosis: correlation of treatment outcome and in vitro susceptibility of fungal isolates. Indian Journal of Ophthalmology 2011 59 6 512 514 2-s2.0-80155213946 10.4103/0301-4738.86328
17. Alastruey-Izquierdo A., Cuenca-Estrella M., Monzón A., Mellado E., Rodríguez-Tudela J. L., Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods. Journal of Antimicrobial Chemotherapy 2008 61 4 805 809 2-s2.0-41149089785 10.1093/jac/dkn022
18. Iqbal N. J., Boey A., Park B. J., Brandt M. E., Determination of in vitro susceptibility of ocular Fusarium spp. isolates from keratitis cases and comparison of clinical and laboratory standards institute M38-A2 and E test methods. Diagnostic Microbiology and Infectious Disease 2008 62 3 348 350 2-s2.0-53949117202 10.1016/j.diagmicrobio.2008.07.003
19. Chander J., Chakrabarti A., Sharma A., Saini J. S., Panigarhi D., Evaluation of calcofluor staining in the diagnosis of fungal corneal ulcer. Mycoses 1993 36 7-8 243 245 2-s2.0-0027524775
20. de Hoog G. S., Guarro J., Gené J., Figueras M. J., Atlas of Clinical Fungi 2009 3rd
21. Institute CLS, Reference Method For Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi 2008 2nd Wayne, Pa, USA Clinical Laboratory Standards Institute
22. Sharma S. L., Keratomycosis in corneal sepsis. Indian Journal of Ophthalmology 1981 29 4 443 445 2-s2.0-0019799216
23. Kulshrestha O. P., Bhargava S., Dube M. K., Keratomycosis: a report of 23 cases. Indian Journal of Ophthalmology 1973 21 2 51 55 2-s2.0-0015856760
24. Bharathi M. J., Ramakrishnan R., Vasu S., Meenakshi R., Palaniappan R., Epidemiological characteristics and laboratory diagnosis of fungal keratitis. A three-year study. Indian Journal of Ophthalmology 2003 51 4 315 321 2-s2.0-0345861902
25. Kumar A., Pandya S., Kavathia G., Microbial keratitis in Gujarat, Western India: findings from 200 cases. The Pan African Medical Journal 2011 10 48
26. Tewari A., Sood N., Vegad M. M., Mehta D. C., Epidemiological and microbiological profile of infective keratitis in Ahmedabad. Indian Journal of Ophthalmology 2012 60 4 267 272
27. Nath R., Baruah S., Saikia L., Devi B., Borthakur A., Mahanta J., Mycotic corneal ulcers in upper Assam. Indian Journal of Ophthalmology 2011 59 5 367 371 2-s2.0-80051992415 10.4103/0301-4738.83613
28. Bharathi M. J., Ramakrishnan R., Meenakshi R., Shivakumar C., Raj L. L., Analysis of the risk factors predisposing to fungal, bacterial & Acanthamoeba keratitis in south India. Indian Journal of Medical Research 2009 130 6 749 757 2-s2.0-74349083245
29. Polack F. M., Kaufman H. E., Newmark E., Keratomycosis. Medical and surgical treatment. Archives of Ophthalmology 1971 85 4 410 416 2-s2.0-0015044986
30. Srinivasan M., Gonzales C. A., George C., Cevallos V., Mascarenhas J. M., Asokan B., Wilkins J., Smolin G., Whitcher J. P., Epidemiology and aetiological diagnosis of corneal ulceration in Madurai, south India. British Journal of Ophthalmology 1997 81 11 965 971 2-s2.0-0030862135
31. Thomas P. A., Leck A. K., Myatt M., Characteristic clinical features as an aid to the diagnosis of suppurative keratitis caused by filamentous fungi. British Journal of Ophthalmology 2005 89 12 1554 1558 2-s2.0-28444474847 10.1136/bjo.2005.076315
32. Srinivasan R., Kanungo R., Goyal J. L., Spectrum of oculomycosis in South India. Acta Ophthalmologica 1991 69 6 744 749 2-s2.0-0026410966
33. Garg P., Gopinathan U., Choudhary K., Rao G. N., Keratomycosis: clinical and microbiologic experience with dematiaceous fungi. Ophthalmology 2000 107 3 574 580 2-s2.0-0034070250 10.1016/S0161-6420(99)00079-2
34. Garg P., Vemuganti G. K., Chatarjee S., Gopinathan U., Rao G. N., Pigmented plaque presentation of dematiaceous fungal keratitis: a clinicopathologic correlation. Cornea 2004 23 6 571 576 2-s2.0-3342977804 10.1097/01.ico.0000126318.90271.3c
35. Bharathi M. J., Ramakrishnan R., Meenakshi R., Mittal S., Shivakumar C., Srinivasan M., Microbiological diagnosis of infective keratitis: comparative evaluation of direct microscopy and culture results. British Journal of Ophthalmology 2006 90 10 1271 1276 2-s2.0-33750348459 10.1136/bjo.2006.096230
36. Liu K., Howell D. N., Perfect J. R., Schell W. A., Morphologic criteria for the preliminary identification of Fusarium, Paecilomyces, and Acremonium species by histopathology. American Journal of Clinical Pathology 1998 109 1 45 54 2-s2.0-0031962926
37. Thomas P. A., Jesudasan C. A. N., Geraldine P., Kaliamurthy J., Adventitious sporulation in Fusarium keratitis. Graefe's Archive for Clinical and Experimental Ophthalmology 2011 249 9 1429 1431 2-s2.0-80052693526 10.1007/s00417-011-1692-y
38. Forster R. K., Rebell G., Wilson L. A., Dematiaceous fungal keratitis. Clinical isolates and management. British Journal of Ophthalmology 1975 59 7 372 376 2-s2.0-0016798884
39. Wilhelmus K. R., Jones D. B., Curvularia keratitis. Transactions of the American Ophthalmological Society 2001 99 111 130
40. Balajee S. A., Borman A. M., Brandt M. E., Cano J., Cuenca-Estrella M., Dannaoui E., Guarro J., Haase G., Kibbler C. C., Meyer W., O'donnell K., Petti C. A., Rodriguez-Tudela J. L., Sutton D., Velegraki A., Wickes B. L., Sequence-based identification of Aspergillus, Fusarium, and mucorales species in the clinical mycology laboratory: where are we and where should we go from here? Journal of Clinical Microbiology 2009 47 4 877 884 2-s2.0-65249137594 10.1128/JCM.01685-08
41. Murphy M., Bernard E. M., Ishimaru T., Armstrong D., Activity of voriconazole (UK-109,496) against clinical isolates of Aspergillus species and its effectiveness in an experimental model of invasive pulmonary aspergillosis. Antimicrobial Agents and Chemotherapy 1997 41 3 696 698 2-s2.0-0031028655
42. Diekema D. J., Messer S. A., Hollis R. J., Jones R. N., Pfaller M. A., Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi. Journal of Clinical Microbiology 2003 41 8 3623 3626 2-s2.0-0043025344 10.1128/JCM.41.8.3623-3626.2003
43. Singh S. M., Sharma S., Chatterjee P. K., Clinical and experimental mycotic keratitis caused by Aspergillus terreus and the effect of subconjunctival oxiconazole treatment in the animal model. Mycopathologia 1990 112 3 127 137 2-s2.0-0025603144 10.1007/BF00436642
44. Sengupta S., Rajan S., Reddy P. R., Thiruvengadakrishnan K., Ravindran R. D., Lalitha P., Vaitilingam C. M., Comparative study on the incidence and outcomes of pigmented versus non pigmented keratomycosis. Indian Journal of Ophthalmology 2011 59 4 291 296 2-s2.0-79959358763 10.4103/0301-4738.81997